mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0001 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
mRNA |
Camptothecin |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
PHA-793887 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.0002 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
mRNA |
niclosamide |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0003 |
mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.0003 |
mRNA |
PD 153035 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
0.0003 |
mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0003 |